Abstract
The efficacy of implantable cardiac defibrillators for prevention of sudden cardiac death (SCD) has been well documented. However, morbidity and complications of these devices have been of major concern. The wearable cardiac defibrillator (WCD) provides an option for protection during this vulnerable period when the risk of SCD is unclear. The subcutaneous implantable cardiac defibrillator (S-ICD) may indeed offer a viable therapeutic option in selected patients at high risk of SCD and in whom pacing is not required. The S-ICD and the WCD represent a further step in evolution of defibrillator technology in the prevention of S-ICD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
